Sgherza N. P105 | Immunosuppressive and biological drugs do not influence progression of MGUS or smoldering multiple myeloma in patients with concomitant autoimmune disorders: preliminary data from a retrospective, single-center study: <a href="https://haematologica.org/search/search?query=N.+Sgherza">N. Sgherza</a>1, <a href="https://haematologica.org/search/search?query=O.+Magazzino">O. Magazzino</a>2, <a href="https://haematologica.org/search/search?query=P.+Curci">P. Curci</a>1, <a href="https://haematologica.org/search/search?query=E.+Resta">E. Resta</a>3, <a href="https://haematologica.org/search/search?query=O.+Battisti">O. Battisti</a>1, <a href="https://haematologica.org/search/search?query=A.+Vitucci">A. Vitucci</a>1, <a href="https://haematologica.org/search/search?query=A.+V.+Russo+Rossi">A. V. Russo Rossi</a>1, <a href="https://haematologica.org/search/search?query=F.+Iannone">F. Iannone</a>4, <a href="https://haematologica.org/search/search?query=P.+Musto">P. Musto</a>1|2 | 1Hematology and Stem Cell Transplantation Unit, AOUC Policlinico; 2Department of Precision and Regenerative Medicine and Ionian Area, “Aldo Moro” University School of Medicine; 3Department of Clinical and Molecular Medicine, Sapienza University; 4Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, “Aldo Moro” University School of Medicine. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.162